Invea Therapeutics, Inc. IPO Research Information

Invea Therapeutics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Invea Therapeutics, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Invea Therapeutics, Inc.	INAI - NASDAQ	Withdrawn	$0.00	$0.00	Withdrawn
Underwriter(s): BofA Securities, Citigroup, Truist Securities
Co-Manager(s): ThinkEquity
Industry: Health Care
Filing(s): Filed 2023-10-20

About Invea Therapeutics, Inc. (adapted from Invea Therapeutics, Inc. prospectus):
They are a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases, or IMIDs.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "INAI" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.